Michael Meredith

Michael Meredith is a finance professional with extensive experience in the pharmaceutical industry and transaction advisory services. Currently serving as Director of US Commercial Finance for Epidiolex at Jazz Pharmaceuticals since September 2023, Michael previously held multiple finance roles at Pfizer from May 2016 to September 2023, including Director of R&D Finance and Senior Manager of OP&A. Prior to Pfizer, Michael gained valuable experience as an Analyst in Transaction Advisory Services at Duff & Phelps from September 2013 to May 2016, and as an intern in the same department in early 2013. Michael's career includes an unconventional period as a Professional Poker Player from June 2005 to September 2011. Michael holds an MBA in Accounting from Rutgers Business School and a BA from the University of Maryland.